IBM Stock: Buy, Hold, or Sell?
Summary
Parkev provides a thorough analysis of IBM's financial turnaround, noting that the company has increased its revenue from a 2021 low of $50 billion to $69 billion today. Parkev highlights the significant improvement in IBM's operating profit margins, which have doubled from 11% to 21% over the same period, marking a ten-year high. This growth is attributed to strategic divestitures and the internal integration of künstliche Intelligenz (AI), which Parkev expects will generate over $1 billion in productivity-driven savings over the next two years.
Parkev emphasizes that IBM's valuation has become significantly more attractive, with its forward P/E ratio dropping from 23 at the start of the year to 16.7. Based on a updated discounted cash flow model, Parkev calculates a fair value of $254 per share, offering a potential 15% upside from the current market price of $220. Parkev concludes that while the stock has faced recent pressure, the risk-to-reward ratio is now favorable for investors.
Mentioned Stocks
Reasoning: Parkev reiterates a medium conviction buy rating based on an intrinsic value calculation of $254 per share, compared to the current price of $220. Parkev points to the expansion of operating margins to 21% and a favorable forward P/E of 16.7 as evidence that the stock is undervalued. Additionally, Parkev values the company's AI-driven productivity gains, which are expected to yield $1 billion in savings, and its leadership in the emerging field of quantum computing.